$0.19 EPS Expected for Penumbra, Inc. (NYSE:PEN) This Quarter

Equities analysts expect Penumbra, Inc. (NYSE:PEN) to announce earnings of $0.19 per share for the current quarter, Zacks reports. Three analysts have provided estimates for Penumbra’s earnings. The highest EPS estimate is $0.24 and the lowest is $0.16. Penumbra posted earnings per share of $0.42 during the same quarter last year, which suggests a negative year over year growth rate of 54.8%. The company is expected to issue its next quarterly earnings report on Tuesday, February 22nd.

On average, analysts expect that Penumbra will report full-year earnings of $0.79 per share for the current financial year, with EPS estimates ranging from $0.76 to $0.83. For the next year, analysts forecast that the business will report earnings of $1.11 per share, with EPS estimates ranging from $0.48 to $1.43. Zacks’ earnings per share averages are a mean average based on a survey of analysts that that provide coverage for Penumbra.

Penumbra (NYSE:PEN) last posted its quarterly earnings data on Wednesday, November 3rd. The company reported $0.12 earnings per share for the quarter, missing the consensus estimate of $0.14 by ($0.02). Penumbra had a net margin of 4.72% and a return on equity of 5.77%. During the same quarter last year, the firm posted $0.06 earnings per share.

Several brokerages have recently issued reports on PEN. Citigroup raised their target price on shares of Penumbra from $335.00 to $340.00 and gave the company a “buy” rating in a research note on Tuesday, August 10th. Truist began coverage on shares of Penumbra in a research note on Wednesday, September 15th. They issued a “buy” rating and a $350.00 target price on the stock. BTIG Research raised their target price on shares of Penumbra from $299.00 to $308.00 and gave the company a “buy” rating in a research note on Tuesday, August 10th. Zacks Investment Research raised shares of Penumbra from a “sell” rating to a “hold” rating in a research note on Tuesday. Finally, Truist Securities started coverage on shares of Penumbra in a research note on Thursday, September 16th. They set a “buy” rating and a $350.00 price objective on the stock. One equities research analyst has rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Buy” and an average target price of $331.00.

In other Penumbra news, CEO Adam Elsesser sold 14,500 shares of the firm’s stock in a transaction that occurred on Monday, September 13th. The shares were sold at an average price of $280.42, for a total transaction of $4,066,090.00. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider James Robert Pray sold 5,000 shares of the firm’s stock in a transaction that occurred on Wednesday, September 1st. The stock was sold at an average price of $271.77, for a total transaction of $1,358,850.00. Following the sale, the insider now owns 1,578 shares in the company, valued at $428,853.06. The disclosure for this sale can be found here. Insiders have sold a total of 63,403 shares of company stock worth $16,942,659 in the last three months. 7.50% of the stock is owned by insiders.

Hedge funds and other institutional investors have recently bought and sold shares of the company. 6 Meridian increased its holdings in Penumbra by 4.6% during the third quarter. 6 Meridian now owns 834 shares of the company’s stock worth $222,000 after buying an additional 37 shares during the last quarter. Great West Life Assurance Co. Can increased its holdings in Penumbra by 0.3% during the second quarter. Great West Life Assurance Co. Can now owns 13,247 shares of the company’s stock worth $3,633,000 after buying an additional 40 shares during the last quarter. Fifth Third Bancorp increased its holdings in Penumbra by 48.3% during the third quarter. Fifth Third Bancorp now owns 129 shares of the company’s stock worth $34,000 after buying an additional 42 shares during the last quarter. Advisors Asset Management Inc. boosted its position in Penumbra by 0.5% during the second quarter. Advisors Asset Management Inc. now owns 8,896 shares of the company’s stock worth $2,438,000 after purchasing an additional 47 shares during the period. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its position in Penumbra by 0.5% during the third quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 11,360 shares of the company’s stock worth $3,027,000 after purchasing an additional 57 shares during the period. Institutional investors own 80.58% of the company’s stock.

Shares of NYSE PEN traded up $3.37 during mid-day trading on Friday, hitting $259.98. The company’s stock had a trading volume of 92,055 shares, compared to its average volume of 270,011. The stock has a market cap of $9.71 billion, a price-to-earnings ratio of 285.69, a price-to-earnings-growth ratio of 15.14 and a beta of 0.26. The company has a debt-to-equity ratio of 0.04, a current ratio of 5.76 and a quick ratio of 3.53. Penumbra has a one year low of $163.49 and a one year high of $320.00. The company’s fifty day simple moving average is $270.30 and its 200-day simple moving average is $267.48.

Penumbra Company Profile

Penumbra, Inc engages in the design, development, manufacture, and marketing of innovative medical devices. It offers thrombectomy, embolization, access, neurosurgical tools, ruby coil system, lantern, penumbra occlusion device (POD) system, packing coil, and indigo systems products. Its target markets include interventional neuroradiologists, neurosurgeons, and interventional neurologists; and interventional radiologists, vascular surgeons, and interventional cardiologists.

See Also: How is the S&P 500 index different from the DJIA?

Get a free copy of the Zacks research report on Penumbra (PEN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Penumbra (NYSE:PEN)

Receive News & Ratings for Penumbra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Penumbra and related companies with MarketBeat.com's FREE daily email newsletter.